NOT YET BECAUSE OF AI, home

Measured AI benefits to people · data as of

Not yet because of AI

Candidates that have not passed the four tests: a drug in Phase III, satellites in orbit, alerts nobody has yet measured a response to. Each one says what would move it onto the main list. These entries carry no grades, because there is nothing to grade yet.

4 entries

  1. The first generative-AI-discovered drug entered Phase III in September 2026 — no AI-discovered drug has yet been approved anywhere.

    Watchlist

    What would change this: A positive 52-week FVC result, then regulatory approval, then patients treated outside a trial — each step moves it closer; approval alone does not make it a "because" entry.

    Phase III started; 0 approvals

  2. Every Cure's AI ranks 75 million drug–disease pairs; its patient wins so far came from clinicians or predate the window.

    Watchlist

    What would change this: A documented patient outcome where the drug–disease match originated from the MATRIX platform, with dates.

    $76MARPA-H; 10 programs

  3. Three FireSat satellites launched in July 2026 to spot 5×5 m fires from orbit; no fire-response outcome has been measured yet.

    Watchlist

    What would change this: A documented detection with a timestamp ahead of other systems and a fire-agency response outcome.

    3satellites in orbit

  4. Google's urban flash-flood model now gives up to 24 hours' notice worldwide; whether anyone acted on an alert hasn't been measured.

    Watchlist

    What would change this: An independent impact evaluation (evacuations, losses) tied to specific alerts.

    24hflash-flood alerts, global